Finally, the use of P815-ULBP1+CD48 cells enabled us to evaluate whether the compromised NKA in MM NK cells is related to NKG2D and/or 2B4 downregulation by assessing the expression of these receptors on NK cells. The gene discussed is CD48; the disease is Miyoshi myopathy.